Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jasper Therapeutics, Inc. (JSPR)
USD0.69
-0.03 (-4.26%)
US NASDAQ Healthcare Biotechnology
Address
2200 Bridge Pkwy 94065
Redwood City, CA, US
Redwood City, CA, US
CEO
Jeetinder Singh Mahal
Website
jaspertx.com
IPO
2020-01-10
CIK 1788028 ISIN US4718712023
Also trades on
NASDAQ Capital Market · JSPR (USD)
NASDAQ Capital Market · JSPRW (USD)
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma, as well as conditioning agents for stem cell transplant in patients with sickle cell disease, Fanconi anemia, and severe combined immunodeficiency. Jasper Therapeutics, Inc. was founded in 2018 and is based in Redwood City, California.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Amplitude Healthcare Acquisition Corporation | AMHCU | 2021-06-07 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.69
-0.03 (-4.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
548.3K
Beta
3.01
Float Shares
13.78M
Free Float %
84.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.23% | +6.56% | +2.85% | -15.88% | -42.92% | -47.60% | -80.23% | -93.85% | -99.04% | -99.02% | -99.02% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (12 ratings, all time)
Buy
Price Targets & DCF
Current price
0.69
Low
3.00
+333.5%
Consensus
41.67
+5,921.7%
Median
55.50
+7,920.2%
High
65.00
+9,293.1%
DCF (Unlevered)
1.45
+108.8%
DCF (Levered)
1.79
+158.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
57% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 6 |
41.67
+5,921.7%
|
Quality scores
Altman Z-Score
-31.22
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%+19.2% Q1'26: +97.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%—
-
Share dilution Biotechnology: -3.4%+5.1% Q1'26: +90.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.02× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 1 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
est: 4.40M (-100.0%)
|
1.11M
1.11M – 1.11M
-74.7% YoY
|
173.8K
173.8K – 173.8K
-84.4% YoY
|
33.88M
33.88M – 33.88M
+19,393.2% YoY
|
25.00M
25.00M – 25.00M
-26.2% YoY
|
25.28M
25.28M – 25.28M
+1.1% YoY
|
| EBITDA |
-74.87M
|
-82.83M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-76.24M
|
-83.88M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-71.27M
est: -65.43M (-8.9%)
|
-75.80M
est: -66.96M (-13.2%)
|
-27.84M
-30.99M – -24.69M
+58.4% YoY
|
-28.70M
-40.26M – -17.14M
-3.1% YoY
|
-21.45M
-40.02M – -2.87M
+25.3% YoY
|
-21.77M
-21.77M – -21.77M
-1.5% YoY
|
-15.49M
-15.49M – -15.49M
+28.9% YoY
|
| SGA |
20.42M
|
20.78M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-4.89
est: -4.54 (-7.8%)
|
-3.95
est: -4.38 (+9.8%)
|
-1.75
-2.02 – -1.61
+60.0% YoY
|
-1.88
-2.63 – -1.12
-7.1% YoY
|
-1.16
-2.61 – -0.19
+38.0% YoY
|
-1.42
-1.42 – -1.42
-22.0% YoY
|
-1.01
-1.01 – -1.01
+28.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
10
Total invested
2.22M
Insider transactions (90d)
0
Beneficial owners (>5%)
46
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adam Morgan | 11.22M | 10.20% | — | — | — | 11.22M | IN | — | 2023-02-27 | ↗ |
| 2 | Balaji Venkataraman | 11.22M | 10.20% | — | — | — | 11.22M | IN | — | 2023-02-27 | ↗ |
| 3 | Velan Capital Investment Management LP | 11.22M | 10.20% | — | — | — | 11.22M | PN | — | 2023-02-27 | ↗ |
| 4 | Velan Capital Management LLC | 11.22M | 10.20% | — | — | — | 11.22M | OO | — | 2023-02-27 | ↗ |
| 5 | BVF Inc. | 9.90M | 9.10% | — | — | — | 9.90M | CO | Delaware | 2023-02-06 | ↗ |
| 6 | BVF Partners L.P. | 9.90M | 9.10% | — | — | — | 9.90M | IA, PN | Delaware | 2023-02-06 | ↗ |
| 7 | Mark N. Lampert | 9.90M | 9.10% | — | — | — | 9.90M | IN | Delaware | 2023-02-06 | ↗ |
| 8 | BVF GP Holdings LLC | 9.30M | 8.50% | — | — | — | 9.30M | OO | Delaware | 2023-02-06 | ↗ |
| 9 | Velan Capital Holdings LLC | 8.39M | 7.70% | — | — | — | 8.39M | OO | — | 2023-02-27 | ↗ |
| 10 | Velan Capital Master Fund LP | 8.39M | 7.70% | — | — | — | 8.39M | PN | — | 2023-02-27 | ↗ |
| 11 | Guy Levy | 6.25M | 5.70% | — | 6.25M | — | 6.25M | IN | Cayman Islands | 2023-01-30 | ↗ |
| 12 | Soleus Capital Group, LLC | 6.25M | 5.70% | — | 6.25M | — | 6.25M | OO | Cayman Islands | 2023-01-30 | ↗ |
| 13 | Soleus Capital Master Fund, L.P. | 6.25M | 5.70% | — | 6.25M | — | 6.25M | FI | Cayman Islands | 2023-01-30 | ↗ |
| 14 | Soleus Capital, LLC | 6.25M | 5.70% | — | 6.25M | — | 6.25M | OO | Cayman Islands | 2023-01-30 | ↗ |
| 15 | Sphera Funds Management Ltd. | 5.69M | 5.13% | — | 5.69M | — | 5.69M | CO | Israel | 2023-10-10 | ↗ |
| 16 | Sphera Global Healthcare GP Ltd. | 5.69M | 5.13% | — | 5.69M | — | 5.69M | CO | Israel | 2023-10-10 | ↗ |
| 17 | Sphera Global Healthcare Management LP | 5.69M | 5.13% | — | 5.69M | — | 5.69M | PN | Israel | 2023-10-10 | ↗ |
| 18 | 98-0518585 | 5.63M | 15.40% | — | — | — | — | PN | England | 2021-10-04 | ↗ |
| 19 | LP | 5.63M | 15.40% | — | — | — | — | PN | England | 2021-10-04 | ↗ |
| 20 | BVF I GP LLC | 5.28M | 4.80% | — | — | — | 5.28M | OO | Delaware | 2023-02-06 | ↗ |
| 21 | Biotechnology Value Fund, L.P. | 5.28M | 4.80% | — | — | — | 5.28M | PN | Delaware | 2023-02-06 | ↗ |
| 22 | BVF II GP LLC | 4.02M | 3.70% | — | — | — | 4.02M | OO | Delaware | 2023-02-06 | ↗ |
| 23 | Biotechnology Value Fund II, L.P. | 4.02M | 3.70% | — | — | — | 4.02M | PN | Delaware | 2023-02-06 | ↗ |
| 24 | James Flexner | 2.84M | 7.80% | — | 2.84M | — | 2.84M | HC, IN | United States of America | 2021-10-04 | ↗ |
| 25 | Thomas Vandervort | 2.84M | 7.80% | — | 2.84M | — | 2.84M | HC, IN | United States of America | 2021-10-04 | ↗ |
| 26 | Avego Healthcare Capital Holdings, LLC | 2.83M | 2.60% | — | — | — | 2.83M | OO | — | 2023-02-27 | ↗ |
| 27 | Avego Healthcare Capital, L.P. | 2.83M | 2.60% | — | — | — | 2.83M | PN | — | 2023-02-27 | ↗ |
| 28 | Avego Management, LLC | 2.83M | 2.60% | — | — | — | 2.83M | OO | — | 2023-02-27 | ↗ |
| 29 | Howard I. Hoffen | 1.68M | 4.59% | 175.0K | 1.50M | 175.0K | 1.50M | IN | — | 2022-04-28 | ↗ |
| 30 | Kenneth F. Clifford | 1.53M | 4.18% | 25.0K | 1.50M | 25.0K | 1.50M | IN | — | 2022-04-28 | ↗ |
| 31 | Metalmark Amplitude Healthcare Holdings LLC | 1.50M | 4.11% | 453.3K | 1.05M | 453.3K | 1.05M | OO | — | 2022-04-28 | ↗ |
| 32 | Amplitude Healthcare Holdings LLC | 1.05M | 2.87% | 1.05M | — | 1.05M | — | OO | — | 2022-04-28 | ↗ |
| 33 | (1) BlackRock, Inc. | 800.0K | 5.30% | — | — | — | — | HC | Delaware | 2024-10-22 | ↗ |
| 34 | Avidity Partners Management LP | 760.0K | 5.10% | — | 760.0K | — | 760.0K | IA, PN | Delaware | 2024-03-27 | ↗ |
| 35 | BVF Partners OS Ltd. | 456.2K | 1.00% | — | — | — | 456.2K | CO | Delaware | 2023-02-06 | ↗ |
| 36 | Biotechnology Value Trading Fund OS LP | 456.2K | 1.00% | — | — | — | 456.2K | PN | Delaware | 2023-02-06 | ↗ |
| 37 | Capital Management Company, L.P. | 250.0K | 0.68% | — | 250.0K | — | 250.0K | IA | Delaware, USA | 2022-02-03 | ↗ |
| 38 | Opportunity Master Fund, Ltd. | 250.0K | 0.68% | — | 250.0K | — | 250.0K | OO | Delaware, USA | 2022-02-03 | ↗ |
| 39 | Shah | 250.0K | 0.68% | — | 250.0K | — | 250.0K | HC | Delaware, USA | 2022-02-03 | ↗ |
| 40 | Vishal Kapoor | 80.5K | 1.00% | — | — | 80.5K | — | IN | — | 2023-02-27 | ↗ |
| 41 | CALC IV LP | 6.00 | 0.10% | — | 3.66M | — | 6.00 | HC, PN | Delaware | 2021-10-04 | ↗ |
| 42 | Beryl Capital Management LLC | — | 11.00% | — | — | — | — | OO | U.S.A. | 2022-02-11 | ↗ |
| 43 | Beryl Capital Management LP | — | 11.00% | — | — | — | — | PN | U.S.A. | 2022-02-11 | ↗ |
| 44 | Beryl Capital Partners II LP | — | 11.00% | — | — | — | — | PN | U.S.A. | 2022-02-11 | ↗ |
| 45 | David A. Witkin | — | 11.00% | — | — | — | — | HC | U.S.A. | 2022-02-11 | ↗ |
| 46 | HC IC HOLDINGS LLC | — | 0.00% | — | — | — | — | OO | — | 2022-04-28 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
10
-48 vs prev Q
New positions
4
Closed positions
48
Increased
5
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 2.67M +— (+0.0%) | 4.88M -1.3M (-21.3%) | 16.09% -1.669 pp | 2.83% -2.996 pp | USD16.31 -88.8% | 8 qtrs — |
| 2 | MORGAN STANLEY | 1.97M +1.2M (+149.4%) | 3.60M +1.7M (+91.7%) | 11.88% +6.622 pp | 0.00% +0.000 pp | USD8.52 -78.5% | 8 qtrs — |
| 3 | ACORN CAPITAL ADVISORS, LLC | 1.79M +403.9K (+29.2%) | 3.27M -21.4K (-0.7%) | 10.78% +1.571 pp | 1.11% -0.563 pp | USD2.26 -19.0% | 2 qtrs — |
| 4 | GOLDMAN SACHS GROUP INC | 1.75M +1.7M (+6,394.9%) | 3.20M +3.1M (+4,894.0%) | 10.53% +10.355 pp | 0.00% +0.000 pp | USD2.09 -12.4% | 7 qtrs — |
| 5 | VANGUARD GROUP INC | 1.33M +293.7K (+28.4%) | 2.43M -30.6K (-1.2%) | 8.00% +1.125 pp | 0.00% +0.000 pp | USD14.10 -87.0% | 8 qtrs — |
| 6 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.10M +— (+0.0%) | 2.01M -605.4K (-23.1%) | 6.64% -0.689 pp | 0.10% -0.050 pp | USD12.93 -85.8% | 8 qtrs — |
| 7 | MILLENNIUM MANAGEMENT LLC | 1.07M +708.8K (+194.2%) | 1.97M +1.1M (+126.2%) | 6.48% +4.047 pp | 0.00% +0.001 pp | USD2.42 -24.4% | 4 qtrs — |
| 8 | CARLYLE GROUP INC. | 1.07M +— (+0.0%) | 1.94M -586.4K (-23.2%) | 6.43% -0.667 pp | 0.01% -0.044 pp | USD28.30 -93.5% | 8 qtrs — |
| 9 | WOODLINE PARTNERS LP | 1.04M +953.0 (+0.1%) | 1.90M -570.1K (-23.0%) | 6.28% -0.645 pp | 0.01% -0.004 pp | USD2.38 -23.1% | 2 qtrs — |
| 10 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 964.8K -64.1K (-6.2%) | 1.77M -683.0K (-27.9%) | 5.82% -1.030 pp | 0.00% 0.000 pp | USD5.06 -63.8% | 5 qtrs — |
| 11 | BOOTHBAY FUND MANAGEMENT, LLC | 794.0K +351.3K (+79.4%) | 1.45M +399.4K (+37.9%) | 4.79% +1.842 pp | 0.02% +0.006 pp | USD2.14 -14.5% | 2 qtrs — |
| 12 | SPHERA FUNDS MANAGEMENT LTD. | 485.4K -144.1K (-22.9%) | 888.3K -609.9K (-40.7%) | 2.93% -1.263 pp | 0.17% -0.144 pp | USD2.98 -38.6% | 8 qtrs — |
| 13 | LION POINT CAPITAL, LP | 465.0K +66.4K (+16.7%) | 851.0K -97.6K (-10.3%) | 2.80% +0.151 pp | 4.40% -0.985 pp | USD4.56 -59.9% | 8 qtrs — |
| 14 | BANK OF AMERICA CORP /DE/ | 293.0K -1.5K (-0.5%) | 536.2K -164.8K (-23.5%) | 1.77% -0.193 pp | 0.00% +0.000 pp | USD23.25 -92.1% | 8 qtrs — |
| 15 | SQUAREPOINT OPS LLC | 281.9K +268.0K (+1,919.5%) | 515.9K +482.7K (+1,452.8%) | 1.70% +1.608 pp | 0.00% +0.001 pp | USD2.01 -9.0% | 3 qtrs — |
| 16 | BLACKROCK, INC. | 236.2K +31.3K (+15.3%) | 432.3K -55.4K (-11.4%) | 1.42% +0.061 pp | 0.00% +0.000 pp | USD16.58 -89.0% | 6 qtrs — |
| 17 | RENAISSANCE TECHNOLOGIES LLC | 227.2K +18.7K (+9.0%) | 415.7K -80.5K (-16.2%) | 1.37% -0.018 pp | 0.00% +0.000 pp | USD2.48 -26.2% | 3 qtrs — |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 211.9K +81.0K (+61.9%) | 387.8K +76.2K (+24.5%) | 1.28% +0.407 pp | 0.00% +0.000 pp | USD16.26 -88.7% | 8 qtrs — |
| 19 | SOLEUS CAPITAL MANAGEMENT, L.P. | 200.0K -1.3M (-86.6%) | 366.0K -3.2M (-89.7%) | 1.21% -8.742 pp | 0.01% -0.166 pp | USD26.87 -93.2% | 8 qtrs — |
| 20 | KNOTT DAVID M JR | 181.4K +10.0K (+5.8%) | 331.9K -76.0K (-18.6%) | 1.09% -0.047 pp | 0.15% -0.011 pp | USD2.35 -22.1% | 2 qtrs — |
| 21 | ADAR1 CAPITAL MANAGEMENT, LLC | 140.0K +140.0K (+100.0%) | 256.2K +256.2K (+100.0%) | 0.84% +0.844 pp | 0.02% +0.019 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 22 | UBS GROUP AG | 126.4K +87.0K (+221.1%) | 231.2K +137.6K (+146.9%) | 0.76% +0.500 pp | 0.00% +0.000 pp | USD4.24 -56.8% | 7 qtrs — |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 104.8K +69.2K (+194.4%) | 191.8K +107.1K (+126.4%) | 0.63% +0.395 pp | 0.00% +0.000 pp | USD4.31 -57.5% | 8 qtrs — |
| 24 | QUARRY LP | 99.5K +99.5K (+100.0%) | 182.1K +182.1K (+100.0%) | 0.60% +0.600 pp | 0.03% +0.029 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 25 | READYSTATE ASSET MANAGEMENT LP | 98.4K +— (+0.0%) | 180.1K -54.1K (-23.1%) | 0.59% -0.062 pp | 0.01% -0.003 pp | USD2.38 -23.1% | 2 qtrs — |
| 26 | JANE STREET GROUP, LLC | 77.8K +77.8K (+100.0%) | 142.4K +142.4K (+100.0%) | 0.47% +0.469 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 27 | GSA CAPITAL PARTNERS LLP | 75.0K +75.0K (+100.0%) | 137.0K +137.0K (+100.0%) | 0.45% +0.452 pp | 0.01% +0.012 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 28 | QUADRATURE CAPITAL LTD | 67.3K +67.3K (+100.0%) | 123.1K +123.1K (+100.0%) | 0.41% +0.406 pp | 0.00% +0.001 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 29 | JACOBS LEVY EQUITY MANAGEMENT, INC | 54.8K +54.8K (+100.0%) | 100.3K +100.3K (+100.0%) | 0.33% +0.331 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 30 | IEQ CAPITAL, LLC | 50.4K +2.3K (+4.8%) | 92.3K -22.2K (-19.4%) | 0.30% -0.016 pp | 0.00% 0.000 pp | USD2.35 -22.1% | 2 qtrs — |
| 31 | CITADEL ADVISORS LLC | 48.2K +3.7K (+8.3%) | 88.2K -17.7K (-16.7%) | 0.29% -0.006 pp | 0.00% +0.000 pp | USD2.34 -21.8% | 8 qtrs — |
| 32 | STATE STREET CORP | 44.7K +— (+0.0%) | 81.8K -24.6K (-23.1%) | 0.27% -0.028 pp | 0.00% +0.000 pp | USD23.48 -92.2% | 8 qtrs — |
| 33 | JAIN GLOBAL LLC | 43.3K +43.3K (+100.0%) | 79.2K +79.2K (+100.0%) | 0.26% +0.261 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 3 qtrs — |
| 34 | ADVISOR GROUP HOLDINGS, INC. | 40.9K -837.0 (-2.0%) | 74.8K -24.9K (-25.0%) | 0.25% -0.031 pp | 0.00% +0.000 pp | USD2.80 -34.6% | 7 qtrs — |
| 35 | NORTHERN TRUST CORP | 34.6K +664.0 (+2.0%) | 63.3K -17.4K (-21.6%) | 0.21% -0.017 pp | 0.00% +0.000 pp | USD20.72 -91.2% | 8 qtrs — |
| 36 | IKARIAN CAPITAL, LLC | 24.1K -1.0K (-4.0%) | 44.1K -15.7K (-26.2%) | 0.15% -0.022 pp | 0.00% -0.003 pp | USD28.30 -93.5% | 8 qtrs — |
| 37 | PANAGORA ASSET MANAGEMENT INC | 19.4K +19.4K (+100.0%) | 35.4K +35.4K (+100.0%) | 0.12% +0.117 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 38 | DIMENSIONAL FUND ADVISORS LP | 18.7K -20.3K (-52.1%) | 34.2K -58.6K (-63.2%) | 0.11% -0.147 pp | 0.00% +0.000 pp | USD16.59 -89.0% | 6 qtrs — |
| 39 | ENGINEERS GATE MANAGER LP | 14.3K +14.3K (+100.0%) | 26.1K +26.1K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 3 qtrs — |
| 40 | SEQUENT PLANNING LLC | 12.5K +— (+0.0%) | 22.9K -6.9K (-23.1%) | 0.08% -0.008 pp | 0.01% -0.003 pp | USD5.04 -63.7% | 3 qtrs — |
| 41 | FMR LLC | 11.9K +50.0 (+0.4%) | 21.9K -6.5K (-22.8%) | 0.07% -0.007 pp | 0.00% +0.000 pp | USD17.88 -89.8% | 6 qtrs — |
| 42 | FEDERATED HERMES, INC. | 4.9K +2.2K (+76.9%) | 9.1K +2.4K (+36.0%) | 0.03% +0.011 pp | 0.00% +0.000 pp | USD3.14 -41.7% | 4 qtrs — |
| 43 | WELLS FARGO & COMPANY/MN | 1.3K -1.0K (-43.5%) | 2.4K -3.1K (-56.5%) | 0.01% -0.008 pp | 0.00% +0.000 pp | USD22.29 -91.8% | 8 qtrs — |
| 44 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.1K +1.1K (+114,000.0%) | 2.1K +2.1K (+104,300.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD1.84 -0.5% | 6 qtrs — |
| 45 | GROUP ONE TRADING, L.P. | 788.00 -16.8K (-95.5%) | 1.4K -40.3K (-96.5%) | 0.00% -0.112 pp | 0.00% 0.000 pp | USD2.38 -23.1% | 2 qtrs — |
| 46 | CITIGROUP INC | 642.00 +642.0 (+100.0%) | 1.2K +1.2K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD1.83 +0.0% | 1 qtrs NEW |
| 47 | US BANCORP \DE\ | 500.00 +— (+0.0%) | 915.00 -275.0 (-23.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD18.81 -90.3% | 6 qtrs — |
| 48 | NATIONAL BANK OF CANADA /FI/ | 160.00 +80.0 (+100.0%) | 291.00 +101.0 (+53.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.38 -45.9% | 8 qtrs — |
| 49 | BNP PARIBAS ARBITRAGE, SNC | 141.00 +— (+0.0%) | 258.00 -78.0 (-23.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD7.43 -75.4% | 7 qtrs — |
| 50 | SBI SECURITIES CO., LTD. | 65.00 -1.0 (-1.5%) | 119.00 -38.0 (-24.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.97 -63.2% | 5 qtrs — |
| 51 | JONES FINANCIAL COMPANIES LLLP | 50.00 +— (+0.0%) | 92.00 -32.0 (-25.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.38 -23.1% | 2 qtrs — |
| 52 | JPMORGAN CHASE & CO | 9.00 -200.0 (-95.7%) | 16.00 -481.0 (-96.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.67 -72.6% | 7 qtrs — |
| 53 | OPTIVER HOLDING B.V. | 7.00 +1.0 (+16.7%) | 13.00 -1.0 (-7.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.14 -14.5% | 2 qtrs — |
| 54 | BARCLAYS PLC | 1.00 -16.1K (-100.0%) | 2.00 -303.7K (-100.0%) | 0.00% -0.108 pp | 0.00% 0.000 pp | USD2.00 -8.5% | 7 qtrs — |
| 55 | CREWE ADVISORS LLC | — -3.1K (-100.0%) | — -7.4K (-100.0%) | 0.00% -0.021 pp | 0.00% -0.001 pp | USD— | 4 qtrs SOLD |
| 56 | ROYAL BANK OF CANADA | — -2.9K (-100.0%) | — -7.0K (-100.0%) | 0.00% -0.020 pp | 0.00% +0.000 pp | USD— | 7 qtrs SOLD |
| 57 | ROSSBY FINANCIAL, LCC | — -2.0 (-100.0%) | — -5.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 58 | STONEPINE CAPITAL MANAGEMENT, LLC | — -20.2K (-100.0%) | — -48.1K (-100.0%) | 0.00% -0.135 pp | 0.00% -0.039 pp | USD— | 2 qtrs SOLD |
| 59 | PROPEL BIO MANAGEMENT, LLC | — -1.0M (-100.0%) | — -2.4M (-100.0%) | 0.00% -6.849 pp | 0.00% -2.451 pp | USD— | 2 qtrs SOLD |
| 60 | IFP ADVISORS, INC | — -122.0 (-100.0%) | — -290.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 61 | TWO SIGMA INVESTMENTS, LP | — -40.4K (-100.0%) | — -96.2K (-100.0%) | 0.00% -0.269 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 62 | MARINER, LLC | — -12.2K (-100.0%) | — -29.0K (-100.0%) | 0.00% -0.081 pp | 0.00% +0.000 pp | USD— | 8 qtrs SOLD |
| 63 | BANK OF MONTREAL /CAN/ | — -111.8K (-100.0%) | — -266.1K (-100.0%) | 0.00% -0.744 pp | 0.00% 0.000 pp | USD— | 4 qtrs SOLD |
| 64 | ARMISTICE CAPITAL, LLC | — -348.0K (-100.0%) | — -828.2K (-100.0%) | 0.00% -2.317 pp | 0.00% -0.012 pp | USD— | 2 qtrs SOLD |
| 65 | VOLEON CAPITAL MANAGEMENT LP | — -21.0K (-100.0%) | — -49.9K (-100.0%) | 0.00% -0.140 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 66 | KINGDON CAPITAL MANAGEMENT, L.L.C. | — -1.3M (-100.0%) | — -3.2M (-100.0%) | 0.00% -8.819 pp | 0.00% -0.391 pp | USD— | 8 qtrs SOLD |
| 67 | DEUTSCHE BANK AG\ | — -160.0K (-100.0%) | — -380.8K (-100.0%) | 0.00% -1.065 pp | 0.00% 0.000 pp | USD— | 7 qtrs SOLD |
| 68 | SIMPLIFY ASSET MANAGEMENT INC. | — -609.1K (-100.0%) | — -1.4M (-100.0%) | 0.00% -4.054 pp | 0.00% -0.027 pp | USD— | 2 qtrs SOLD |
| 69 | SOWELL FINANCIAL SERVICES LLC | — -10.4K (-100.0%) | — -24.8K (-100.0%) | 0.00% -0.069 pp | 0.00% -0.001 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 252.8K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 1.5K | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 4.0K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 296.97 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 687.0K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 1.5K | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 819.94 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 331.15 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 36.52 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 5.13 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
15
Sells
0
Shares acquired
338.5K
Shares disposed
—
Cash buys
8.00
Cash sales
—
Net activity
+338,500
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | Mahal Jeetinder Singh | Director / Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.35 | 675.0K | 500,000 | D | ↗ |
| 2026-01-02 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 1.84 | 165.6K | 90,000 | D | ↗ |
| 2026-01-02 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 234,000 | 1.84 | 430.6K | 234,000 | D | ↗ |
| 2026-01-02 | CROSS HERB | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 1.84 | 165.6K | 90,000 | D | ↗ |
| 2025-09-22 | WIGGANS THOMAS G | Director | P-Purchase | A | Common Stock Warrant (right to buy) | 41,000 | 2.92 | 119.7K | 41,000 | I | ↗ |
| 2025-09-22 | Shizuru Judith Anne | Director | P-Purchase | A | Common Stock Warrant (right to buy) | 41,000 | 2.92 | 119.7K | 41,000 | D | ↗ |
| 2025-09-22 | MARTELL RON | Director / Officer | P-Purchase | A | Voting Common Stock | 41,000 | 2.43 | 99.6K | 74,118 | D | ↗ |
| 2025-09-22 | Lucas Svetlana | Director | P-Purchase | A | Common Stock Warrant (right to buy) | 20,000 | 2.92 | 58.4K | 20,000 | D | ↗ |
| 2025-07-03 | WIGGANS THOMAS G | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | Shizuru Judith Anne | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | Nolet Chris | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | Lucas Svetlana | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | Kapoor Vishal | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | EMSTER KURT VON | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-07-03 | Brun Scott C. | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 6.77 | 50.8K | 7,500 | D | ↗ |
| 2025-06-04 | Tucker Edwin Jonathan | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 6.00 | 540.0K | 90,000 | D | ↗ |
| 2025-06-04 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 6.00 | 540.0K | 90,000 | D | ↗ |
| 2025-06-04 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 234,000 | 6.00 | 1.40M | 234,000 | D | ↗ |
| 2025-06-04 | CROSS HERB | Officer | A-Award | A | Stock Option (right to buy) | 90,000 | 6.00 | 540.0K | 90,000 | D | ↗ |
| 2025-02-13 | Tucker Edwin Jonathan | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 6.20 | 310.0K | 50,000 | D | ↗ |
| 2025-02-13 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 6.20 | 310.0K | 50,000 | D | ↗ |
| 2025-02-13 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 130,000 | 6.20 | 806.0K | 130,000 | D | ↗ |
| 2025-02-13 | CROSS HERB | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 6.20 | 310.0K | 50,000 | D | ↗ |
| 2024-12-12 | Mahal Jeetinder Singh | Officer | M-Exempt | A | Voting Common Stock | 900 | 7.10 | 6.4K | 25,909 | D | ↗ |
| 2024-09-12 | Mahal Jeetinder Singh | Officer | M-Exempt | A | Stock Option (right to buy) | 900 | 7.10 | 6.4K | 14,672 | — | ↗ |
| 2024-06-18 | Lucas Svetlana | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 23.19 | 347.9K | 15,000 | — | ↗ |
| 2024-06-12 | Mahal Jeetinder Singh | Officer | M-Exempt | A | Voting Common Stock | 900 | 7.10 | 6.4K | 25,909 | — | ↗ |
| 2024-06-10 | MARTELL RON | Director / Officer | A-Award | A | Performance Restricted Stock Units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2024-06-07 | Tucker Edwin Jonathan | Officer | A-Award | A | Voting Common Stock | 400 | 4.17 | 1.7K | 400 | — | ↗ |
| 2024-06-06 | WIGGANS THOMAS G | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | Shizuru Judith Anne | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | Nolet Chris | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | Kapoor Vishal | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | French Anna Louise | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | EMSTER KURT VON | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-06-06 | Brun Scott C. | Director | A-Award | A | Stock Option (right to buy) | 7,500 | 25.41 | 190.6K | 7,500 | — | ↗ |
| 2024-03-12 | Mahal Jeetinder Singh | Officer | M-Exempt | A | Voting Common Stock | 900 | 7.10 | 6.4K | 25,909 | — | ↗ |
| 2024-02-15 | Tucker Edwin Jonathan | Officer | A-Award | A | Stock Option (right to buy) | 45,000 | 17.95 | 807.8K | 45,000 | — | ↗ |
| 2024-02-15 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 17.95 | 718.0K | 40,000 | — | ↗ |
| 2024-02-15 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 17.95 | 1.80M | 100,000 | — | ↗ |
| 2024-02-15 | CROSS HERB | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 17.95 | 718.0K | 40,000 | — | ↗ |
| 2024-02-08 | Velan Capital Investment Management LP | 10% Owner | P-Purchase | A | Common Stock, par value $0.0001 per share | 350,000 | 12.95 | 4.53M | 1,188,500 | — | ↗ |
| 2024-02-08 | Carlyle Group Inc. | 10% Owner | P-Purchase | A | Voting Common Stock | 190,000 | 12.95 | 2.46M | 1,066,189 | — | ↗ |
| 2023-11-28 | WIGGANS THOMAS G | Director | P-Purchase | A | Voting Common Stock | 10,000 | 0.65 | 6.5K | 50,000 | — | ↗ |
| 2023-11-21 | WIGGANS THOMAS G | Director | P-Purchase | A | Voting Common Stock | 10,000 | 0.64 | 6.4K | 40,000 | — | ↗ |
| 2023-11-20 | WIGGANS THOMAS G | Director | P-Purchase | A | Voting Common Stock | 10,000 | 0.63 | 6.3K | 30,000 | — | ↗ |
| 2023-11-17 | WIGGANS THOMAS G | Director | P-Purchase | A | Voting Common Stock | 10,000 | 0.60 | 6.0K | 20,000 | — | ↗ |
| 2023-11-16 | WIGGANS THOMAS G | Director | P-Purchase | A | Voting Common Stock | 10,000 | 0.60 | 6.0K | 10,000 | — | ↗ |
| 2023-11-01 | WIGGANS THOMAS G | Director | A-Award | A | Stock Option (right to buy) | 110,000 | 0.69 | 75.9K | 110,000 | — | ↗ |
| 2023-10-13 | Lis William | Director | S-Sale | D | Voting Common Stock | 7,965 | 0.85 | 6.8K | 53,521 | — | ↗ |
| 2023-10-12 | Mahal Jeetinder Singh | Officer | F-InKind | D | Voting Common Stock | 37,126 | 0.85 | 31.6K | 250,097 | — | ↗ |
| 2023-10-12 | MARTELL RON | Director / Officer | F-InKind | D | Voting Common Stock | 87,531 | 0.85 | 74.4K | 331,188 | — | ↗ |
| 2023-09-22 | CROSS HERB | Officer | A-Award | A | Stock Option (right to buy) | 550,000 | 0.78 | 429.0K | 550,000 | — | ↗ |
| 2023-06-20 | Brun Scott C. | Director | A-Award | A | Stock Option (right to buy) | 94,000 | 1.35 | 126.9K | 94,000 | — | ↗ |
| 2023-06-13 | Mahal Jeetinder Singh | Officer | M-Exempt | A | Voting Common Stock | 9,000 | 0.71 | 6.4K | 296,223 | — | ↗ |
| 2023-06-12 | Tucker Edwin Jonathan | Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 1.62 | 648.0K | 400,000 | — | ↗ |
| 2023-06-07 | Shizuru Judith Anne | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | Nolet Chris | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | Lis William | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | Klein Lawrence Otto | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | Kapoor Vishal | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | French Anna Louise | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-06-07 | EMSTER KURT VON | Director | A-Award | A | Stock Option (right to buy) | 47,000 | 1.60 | 75.2K | 47,000 | — | ↗ |
| 2023-04-14 | French Anna Louise | Director | S-Sale | D | Voting Common Stock | 7,000 | 1.48 | 10.4K | 23,750 | — | ↗ |
| 2023-04-13 | Lis William | Director | S-Sale | D | Voting Common Stock | 8,500 | 1.44 | 12.2K | 61,486 | — | ↗ |
| 2023-04-13 | EMSTER KURT VON | Director | S-Sale | D | Voting Common Stock | 9,075 | 1.49 | 13.5K | 21,175 | — | ↗ |
| 2023-04-12 | Mahal Jeetinder Singh | Officer | F-InKind | D | Voting Common Stock | 37,126 | 1.46 | 54.2K | 287,223 | — | ↗ |
| 2023-04-12 | MARTELL RON | Director / Officer | F-InKind | D | Voting Common Stock | 87,531 | 1.46 | 127.8K | 418,719 | — | ↗ |
| 2023-03-17 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 1.87 | 654.5K | 350,000 | — | ↗ |
| 2023-03-17 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 1.87 | 935.0K | 500,000 | — | ↗ |
| 2023-02-16 | Kapoor Vishal | Director | — | D | Voting Common Stock | 0 | 0.00 | — | 43,750 | — | ↗ |
| 2023-02-02 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,093,831 | 1.78 | 1.95M | 1,093,831 | — | ↗ |
| 2023-01-27 | Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | P-Purchase | A | Voting Common Stock | 2,666,666 | 1.50 | 4.00M | 8,519,648 | — | ↗ |
| 2023-01-27 | Carlyle Group Inc. | 10% Owner | P-Purchase | A | Voting Common Stock | 3,133,333 | 1.50 | 4.70M | 8,761,891 | — | ↗ |
| 2023-01-25 | Velan Capital Investment Management LP | 10% Owner | — | I | Earnout Shares | 181,312 | 15.00 | 2.72M | 0 | — | ↗ |
| 2023-01-25 | ROCHE HOLDING LTD | Director | S-Sale | D | Voting Common Stock | 75,000 | 1.89 | 141.8K | 4,549,606 | — | ↗ |
| 2022-10-12 | Shizuru Judith Anne | Director | A-Award | A | Voting Common Stock | 29,500 | 0.00 | — | 1,159,012 | — | ↗ |
| 2022-10-12 | Nolet Chris | Director | A-Award | A | Voting Common Stock | 32,500 | 0.00 | — | 32,500 | — | ↗ |
| 2022-10-12 | Mahal Jeetinder Singh | Officer | A-Award | A | Voting Common Stock | 214,722 | 0.00 | — | 324,349 | — | ↗ |
| 2022-10-12 | MARTELL RON | Director / Officer | A-Award | A | Voting Common Stock | 506,250 | 0.00 | — | 506,250 | — | ↗ |
| 2022-10-12 | Lis William | Director | A-Award | A | Voting Common Stock | 29,500 | 0.00 | — | 69,986 | — | ↗ |
| 2022-10-12 | Klein Lawrence Otto | Director | A-Award | A | Voting Common Stock | 24,500 | 0.00 | — | 24,500 | — | ↗ |
| 2022-10-12 | French Anna Louise | Director | A-Award | A | Voting Common Stock | 30,750 | 0.00 | — | 30,750 | — | ↗ |
| 2022-10-12 | EMSTER KURT VON | Director | A-Award | A | Voting Common Stock | 30,250 | 0.00 | — | 30,250 | — | ↗ |
| 2022-08-01 | Carlyle Group Inc. | 10% Owner | — | I | Voting Common Stock | 0 | 0.00 | — | 5,628,558 | — | ↗ |
| 2022-06-24 | Lis William | Director | S-Sale | D | Voting Common Stock | 24,743 | 2.08 | 51.4K | 40,486 | — | ↗ |
| 2022-04-07 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 48,441 | 0.00 | — | 48,441 | — | ↗ |
| 2022-03-21 | Shizuru Judith Anne | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 0.00 | — | 78,045 | — | ↗ |
| 2022-03-21 | Nolet Chris | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 3.54 | 276.3K | 78,045 | — | ↗ |
| 2022-03-21 | Mahal Jeetinder Singh | Officer | A-Award | A | Stock Option (right to buy) | 87,272 | 0.00 | — | 87,272 | — | ↗ |
| 2022-03-21 | MARTELL RON | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,704,328 | 3.54 | 6.03M | 1,704,328 | — | ↗ |
| 2022-03-21 | Lis William | Director / Officer | A-Award | A | Stock Option (right to buy) | 7,500 | 3.54 | 26.6K | 7,500 | — | ↗ |
| 2022-03-21 | Klein Lawrence Otto | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 3.54 | 276.3K | 78,045 | — | ↗ |
| 2022-03-21 | Heller Kevin N. | Officer | A-Award | A | Stock Option (right to buy) | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2022-03-21 | French Anna Louise | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 0.00 | — | 78,045 | — | ↗ |
| 2022-03-21 | EMSTER KURT VON | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 0.00 | — | 78,045 | — | ↗ |
| 2022-03-21 | Abingworth LLP | Director | A-Award | A | Stock Option (right to buy) | 78,045 | 0.00 | — | 78,045 | — | ↗ |
| 2022-03-15 | MARTELL RON | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | VENKATARAMAN BALAJI | — | D-Return | A | Class B Common Stock | 200,000 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Shizuru Judith Anne | Director | — | D | Voting Common Stock | 0 | 0.00 | — | 1,129,512 | — | ↗ |
| 2021-09-24 | ROCHE HOLDING LTD | 10% Owner | — | D | Voting Common Stock | 0 | 0.00 | — | 4,624,606 | — | ↗ |
| 2021-09-24 | Qiming U.S. Healthcare Fund II, L.P. | 10% Owner | — | D | Voting Common Stock | 0 | 0.00 | — | 5,852,982 | — | ↗ |
| 2021-09-24 | Nolet Chris | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Mahal Jeetinder Singh | Officer | — | D | Stock Option (right to buy) | 182,713 | 0.71 | 129.7K | 0 | — | ↗ |
| 2021-09-24 | Lis William | Director / Officer | — | D | Stock Option (right to buy) | 229,095 | 0.71 | 162.7K | 0 | — | ↗ |
| 2021-09-24 | Klein Lawrence Otto | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Heller Kevin N. | Officer | — | D | Stock Option (right to buy) | 657,769 | 0.71 | 467.0K | 0 | — | ↗ |
| 2021-09-24 | HOFFEN HOWARD I | — | M-Exempt | A | Class B Common Stock | 2,300,000 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | French Anna Louise | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | EMSTER KURT VON | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,628,558 | — | ↗ |
| 2021-09-24 | Clifford Kenneth F | — | D-Return | A | Class B Common Stock | 200,000 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Amplitude Healthcare Holdings LLC | 10% Owner | M-Exempt | A | Class B Common Stock | 2,300,000 | 0.00 | — | 0 | — | ↗ |
| 2021-09-24 | Abingworth LLP | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,628,558 | — | ↗ |
| 2021-04-23 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 151,719 | 9.92 | 1.51M | 895,059 | — | ↗ |
| 2021-04-21 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 1,164 | 9.92 | 11.5K | 1,046,778 | — | ↗ |
| 2021-04-19 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 2,060 | 9.97 | 20.5K | 1,047,942 | — | ↗ |
| 2021-02-26 | Shizuru Judith Anne | Director | — | D | Stock Option (right to buy) | 146,170 | 0.71 | 103.8K | 0 | — | ↗ |
| 2021-02-22 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 698 | 10.50 | 7.3K | 1,050,002 | — | ↗ |
| 2021-02-19 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 2,112 | 10.50 | 22.2K | 1,050,700 | — | ↗ |
| 2021-02-18 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 10,000 | 10.45 | 104.5K | 1,052,812 | — | ↗ |
| 2021-02-05 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 212 | 10.40 | 2.2K | 1,062,812 | — | ↗ |
| 2021-01-14 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 101 | 10.40 | 1.1K | 1,063,024 | — | ↗ |
| 2021-01-08 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 10,000 | 10.25 | 102.5K | 1,063,125 | — | ↗ |
| 2020-12-30 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 75 | 10.25 | 768.75 | 1,073,125 | — | ↗ |
| 2020-12-29 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 18 | 10.25 | 184.50 | 1,073,200 | — | ↗ |
| 2020-12-28 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 10,000 | 10.20 | 102.0K | 1,073,218 | — | ↗ |
| 2020-12-22 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 10,000 | 10.15 | 101.5K | 1,083,218 | — | ↗ |
| 2020-12-15 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 10,000 | 10.15 | 101.5K | 1,093,218 | — | ↗ |
| 2020-12-14 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 5,000 | 10.05 | 50.3K | 1,103,218 | — | ↗ |
| 2020-12-11 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 5,000 | 10.05 | 50.3K | 1,108,218 | — | ↗ |
| 2020-12-07 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 1 | 10.05 | 10.05 | 1,113,218 | — | ↗ |
| 2020-09-21 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,000 | 10.00 | 10.0K | 1,113,230 | — | ↗ |
| 2020-09-18 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,000 | 10.00 | 10.0K | 1,114,230 | — | ↗ |
| 2020-09-16 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 20 | 9.99 | 199.80 | 1,115,230 | — | ↗ |
| 2020-09-15 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 800 | 9.99 | 8.0K | 1,115,250 | — | ↗ |
| 2020-09-11 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 682 | 9.99 | 6.8K | 1,116,050 | — | ↗ |
| 2020-09-08 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1 | 9.99 | 9.99 | 1,116,732 | — | ↗ |
| 2020-09-04 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A common stock, par value $0.0001 per share | 11 | 10.73 | 118.03 | 1,113,219 | — | ↗ |
| 2020-08-17 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,699 | 9.99 | 17.0K | 1,116,733 | — | ↗ |
| 2020-08-13 | GLAZER CAPITAL, LLC | 10% Owner | S-Sale | D | Class A Common Stock | 1,699 | 9.99 | 17.0K | 1,118,432 | — | ↗ |
| 2020-08-10 | GLAZER CAPITAL, LLC | 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 1,120,131 | — | ↗ |
| 2020-01-06 | Kapoor Vishal | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-03 | VENKATARAMAN BALAJI | Director / Officer / 10% Owner | J-Other | D | Class B Common Stock | 375,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2020-01-03 | HOFFEN HOWARD I | Director / 10% Owner | J-Other | D | Class B Common Stock | 375,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2020-01-03 | Clifford Kenneth F | Officer / 10% Owner | J-Other | D | Class B Common Stock | 375,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2020-01-03 | Amplitude Healthcare Holdings LLC | 10% Owner | J-Other | D | Class B Common Stock | 375,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2019-11-19 | VENKATARAMAN BALAJI | Director / Officer / 10% Owner | — | I | Class B Common Stock | 2,875,000 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | Reicin Glenn | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | MARIO ERNEST | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | HOFFEN HOWARD I | Director / 10% Owner | — | I | Class B Common Stock | 2,875,000 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | ESHELMAN FREDRIC N | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | DOLAN PETER R | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | Clifford Kenneth F | Officer / 10% Owner | — | I | Class B Common Stock | 2,875,000 | 0.00 | — | 0 | — | ↗ |
| 2019-11-19 | Amplitude Healthcare Holdings LLC | 10% Owner | — | D | Class B Common Stock | 2,875,000 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
16.25M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2022 | Ronald Martell President and Chief Executive Officer | 509.7K | — | 399.9K | 4.48M | 226.8K | 25.0K | 5.64M | 86.50% | ↗ |
| 2 | 2022 | Jeet Mahal Chief Operating and Financial Officer and Corporate Secretary | 418.3K | — | 169.6K | 358.4K | 161.2K | — | 1.11M | 47.68% | ↗ |
| 3 | 2022 | William Lis Former Executive Chairman, Chief Executive Officer and President | 110.4K | — | 341.8K | 343.3K | — | 242.1K | 1.04M | 66.02% | ↗ |
| 4 | 2022 | Kevin N. Heller, M.D. Former Executive Vice President, Research and Development | 177.2K | — | — | 6.7K | — | 291.5K | 475.4K | 1.42% | ↗ |
| 5 | 2021 | William Lis Former Executive Chairman, Chief Executive Officer and President | 459.3K | — | — | — | 220.0K | — | 679.3K | 0.00% | ↗ |
| 6 | 2021 | Kevin N. Heller, M.D. Former Executive Vice President, Research and Development | 454.4K | — | — | — | 163.6K | — | 618.0K | 0.00% | ↗ |
| 7 | 2021 | Jeet Mahal Chief Operating and Financial Officer and Corporate Secretary | 355.4K | — | — | — | 105.8K | — | 461.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jeetinder Singh Mahal | President, COO, CEO & Director | 610.1K | male |
| Herbert C. Cross | Chief Financial Officer & Corporate Secretary | 603.9K | male |
| Thomas G. Wiggans | Executive Chairman | 70.0K | male |
| Judith Anne Shizuru | Co-Founder, Member of Scientific Advisory Board & Director | 46.3K | — |
| Alex Gray | Head of Investor Relations | — | — |
| Luca Di Noto | Senior Vice President of Technical Operations | — | — |
| Matthew Ford | Senior Vice President of Human Resources | — | male |
| Patricia Carlos | Senior Vice President of Regulatory Affairs & Quality | — | female |
| Daniel C. Adelman | Acting Chief Medical Officer, Member of Scientific Advisory Board & Senior Clinical Advisor | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for JSPR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
